Literature DB >> 622815

Standardization of the HLA typing method and reagents. Report of a workshop held on November 11, 1976, by the Bureau of Biologics, Food and Drug Administration, United States Department of Health, Education and Welfare.

K K Mittal.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 622815     DOI： 10.1111/j.1423-0410.1978.tb02882.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN： 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  7 in total

1.  Immune thrombocytopenia complicating pulmonary tuberculosis: case report and investigation of mechanisms.

Authors:  R J Boots; A W Roberts; D McEvoy
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

2.  HLA-antigens in Italian type 1 diabetic patients: role of DR3/DR4 antigens and breast feeding in the onset of the disease.

Authors:  E Bognetti; F Meschi; C Malavasi; M R Pastore; A Sergi; M T Illeni; C Maffeis; L Pinelli; G Chiumello
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

3.  HLA and hypertrophic cardiomyopathy.

Authors:  F B Ren; Y Z Rong; X R Yu; M H Zhao; T M Zhao; W J Gu
Journal:  Acta Acad Med Wuhan       Date:  1985

4.  A quantitative radioimmunoassay for membranous and soluble H-Y antigen typing.

Authors:  M Casanova-Bettane; F Latron; H Jakob; M Fellous
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

5.  The role of HLA antigens in disease.

Authors:  K K Mittal
Journal:  Indian J Pediatr       Date:  1980 Sep-Oct       Impact factor: 1.967

6.  H-Y antigen in Swyer syndrome and the genetics of XY gonadal dysgenesis.

Authors:  C A Moreira-Filho; S P Toledo; V R Bagnolli; O Frota-Pessoa; H Bisi; A Wajntal
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

7.  Association of the H-Y male antigen with beta2-microglobulin on human lymphoid and differentiated mouse teratocarcinoma cell lines.

Authors:  M Fellous; E Günther; R Kemler; J Wiels; R Berger; J L Guenet; H Jakob; F Jacob
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.